Curcumin Conjugates Induce Apoptosis Via a Mitochondrion Dependent Pathway in MCF-7 and MDA-MB-231 Cell Lines

  • Published : 2013.10.30


In order to enhance the bioavailability of curcumin its conjugates with piperic acid and glycine were synthesized by esterifying the 4 and 4' phenolic hydroxyls, the sites of metabolic conjugation. Antiproliferative and apoptotic efficacy of synthesized conjugates was investigated in MCF-7 and MDA-MB-231 cell lines. $IC_{50}$ values of di-O-glycinoyl (CDG) and di-O-piperoyl (CDP) esters of curcumin were found to be comparable with that of curcumin. Both conjugates induced chromatin condensation fragmentation and apoptotic body formation. CDP exposure to MCF-7 cells induced apoptosis initiating loss of mitochondrial membrane potential (${\Delta}{\Psi}m$) followed by inhibition of translocation of transcription factor NF-${\kappa}B$ and release of Cytochrome-C. Reactive oxygen species (ROS) production was evaluated by fluorescent activated cell sorter. Change in ratio of Bcl2/Bclxl was observed, suggesting permeablization of mitochondrial membrane leading to the release of AIF, Smac and other apoptogenic molecules. DNA fragmentation as a hallmark for apoptosis was monitored by TUNEL as well as agrose gel electrophoresis. Thus, it was proven that conjugation does not affect the therapeutic potential of parent molecule in vitro, while these could work in vivo as prodrugs with enhanced pharmacokinetic profile. Pharmacokinetics of these molecules under in vivo conditions is a further scope of this study.


  1. Anto RJ, Mukhopadhyay A, Denning K, Aggarwal BB (2002). Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of $Bcl_2\;and\;Bcl_{xl}$. Carcinogenesis, 23, 143-50.
  2. Aggarwal BB, Shishodia S (2004). Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann NY Acad Sci, 1030, 434-41.
  3. Almeida LP, Cherubino APF Alves RJ, Dufosse L, Gloria MBA (2005). Separation and determination of the physico-chemical characteristics of curcumin, demethoxycurcumin and bisdemethoxycurcumin. Food Res Int, 38, 1039-44.
  4. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007). Bioavailability of curcumin: problem and promises. Mol Pharm, 4, 807-18.
  5. Antonsson B, Montessuit S, Lauper S, Eskes R, Martinou JC (2000). Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochemistry, 345, 271-8.
  6. Asa BG, Roberta AG (2008). Heart mitochondria: gates of life and death. Cardiovasc Res, 77, 334-43.
  7. Atsumi T, Fujisawa S, Tonosaki K (2005). Relationship between intracellular ROS production and membrane mobility in curcumin and tetrahydrocurcumin-treated human gingival fibroblasts and human submandibular gland carcinoma cells. Oral Dis, 11, 236-42.
  8. Barzegar A, Moosavi-Movahedi AA (2011). Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin. PLoS One, 6, 26012.
  9. Bleicken S, Classen M, Padmavathi PV, et al (2010). Molecular details of Bax activation, oligomerization, and membrane insertion. J Biol Chem, 285, 6636-47.
  10. Eck-Enriquez K, Kiefer TL, Spriggs LL, Hill SM (2000). Pathways through which a regimen of melatonin and retinoic acid induces apoptosis in MCF-7 human breast cancer cells. Breast Cancer Res Treat, 61, 229-39.
  11. Bursch W (2001). The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ, 8, 569-81.
  12. Chen QY, Lu GH, Wu YQ, et al (2010). Curcumin induces mitochondria pathway mediated cell apoptosis in A549 lung adenocarcinoma cells. Oncol Rep, 23, 1285-92.
  13. Chi S, Kitanaka C, Noguchi K (1999). Oncogenic ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. Oncogene, 18, 2281-90.
  14. Fandy TE, Shankar S, Srivastava RK (2008). Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells. Mol Cancer, 7, 60.
  15. Fang J, Lu J, Holmgren A (2005). Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J Biol Chem, 280, 25284-90.
  16. Hail NJr, Lotan R (2000). Mitochondrial permeability transition is a central coordinating event in N-(4-hydroxyphenyl) retinamide-induced apoptosis. Cancer Epidemiol Biomarkers Prev, 9, 1293-301.
  17. Hegde R, Srinivasula SM, Zhang Z, et al (2002). Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem, 277, 432-8.
  18. Hsu YC, Weng HC, Shiurulin, Chien Y (2007) Curcuminoids-cellular uptake by human primary colon cancer cells As quantitated by a sensitive HPLC assay and its relation with the inhibition of proliferation and apoptosis. J Agric Food Chem, 55, 8213-22.
  19. Kitanaka C, Namiki T, Noguchi K, et al (1997). Caspase-dependent apoptosis of COS-7 cells induced by bax overexpression: differential effects of $Bcl_2\;and\;Bcl_{xl}$ on bax-induced caspase activation and apoptosis. Oncogene, 15, 1763-72.
  20. Hussain AR, Ahmed M, Al-Jomah NA, et al (2008). Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines. Mol Cancer Ther, 7, 3318-29.
  21. Ikan R (1991). Natural Products, A Laboratory Guide, 2nd ed.; Academic Press: New York.
  22. Kagawa S, Pearson SA, Ji L, et al (2000). Binary adenoviral vector system for expressing high levels of the proapoptotic gene bax. Gene Ther, 7, 75-9.
  23. Kulikov AV, Shilov ES, Mufazalov IA, et al (2012). Cytochrome c: the Achilles' heel in apoptosis. Cell Mol Life Sci, 69, 1787-97.
  24. Kumar S, Narain U, Tripathi S, Misra K (2001). Syntheses of curcumin bioconjugates and study of their antibacterial activities against a-Lactamase-Producing Microorganisms. Bioconjugate Chem, 12, 464-9.
  25. Kunwar A, Jayakumar S, Srivastava AK, Priyadarsini KI (2012). Dimethoxycurcumin-induced cell death in human breast carcinoma MCF7 cells: evidence for pro-oxidant activity, mitochondrial dysfunction, and apoptosis. Arch Toxicol, 86, 603-14.
  26. Lao CD, Ruffin MT, Normolle D, et al (2006). Dose escalation of curcuminoids formulation. BMC Complement Altern Med, 6, 10.
  27. Lesauskaite V, Ivanoviene L (2002). Programmed cell death: molecular mechanisms and detection. Medicina Kaunas, 38, 869-75.
  28. Liang Y, Yan C, Schor NF (2001). Apoptosis in the absence of caspase-3. Oncogene, 20, 6570-8.
  29. Nunaez G, Benedict MA, Yuanmimg H, Inohara N (1998). Caspases: the proteases of the apoptotic pathway. Oncogene, 17, 3237-45.
  30. Mishra S, Kapoor N, Mubarak Ali A, et al (2005b). Differential apoptotic and redox regulatory activities of curcumin and its derivatives. Free Radic Biol Med, 38, 1353-60.
  31. Mishra S, Narian U, Mishra R, Misra K (2005a). Design development and synthesis of mixed bioconjugates of piperic acids-glycine, curcumin-glycine, /alanine and curcumin-glycine -piperic acids and their antibacterial and antifungal properties. Bioorg Med Chem, 13, 1477-86.
  32. Miyashita T, Reed JC (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-9.
  33. Oberhammer F, Wilson JW, Dive C, et al (1993). Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J, 12, 3679-84.
  34. Rashmi R, Kumar S, Karunagaran D (2005). Human colon cancer cells lacking bax resist curcumin-induced apoptosis and bax requirement is dispensable with ectopic expression of smac or downregulation of $Bcl_{xl}$. Carcinogenesis, 26, 713-23.
  35. Rosse T, Olivier R, Monney L, et al (1998). $Bcl_2$ prolongs cell survival after Bax-induced release of cytochrome C. Nature, 391, 496-9.
  36. Rudy A, Anton NL, Barth N, et al (2008). Role of smac in cephalostatin-induced cell death. Cell Death Differ, 15, 1930-40.
  37. Saraste A, Pulkki K (2000). Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res, 45, 528-37.
  38. Singh DV, Misra K (2009). Curcuminoids as inhibitors of thioredoxin reductase: a receptor based pharmacophore study with distance mapping of the active site. Bioinformation, 4, 187-92.
  39. Shimizu S, Narita M, Tsujimoto Y (1999). $Bcl_2$ family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature, 399, 483-7.
  40. Shoba G, Joy D, Joseph T, et al (1998). Inffluence of piperine on pharmacokinetics of curcumin in animals and human volunteers. Planta Medica, 64, 353-6.
  41. Singh DV, Godbole MM, Misra K (2013). A plausible explanation for enhanced bioavailability of P-gp substrates in presence of piperine: simulation for next generation of P-gp inhibitors. J Mol Mod, 19, 227-38.
  42. Strasser EM, Wessner B, Manhart N, Roth E (2005). The relationship between the anti-inflammatory effects of curcumin and cellular glutathione content in myelomonocytic cells. Biochem Pharmacol, 70, 552-9.
  43. Susin SA, Zamzami N, Castedo M, et al (1997). The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95-and ceramide-induced apoptosis. J Exp Med, 186, 25-37.
  44. Suzuki Y, Imai Y, Nakayama H, et al (2001). A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell, 8, 613-21.
  45. Uddin S, Hussain AR, Manogaran PS, et al (2005). Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma. Oncogene, 24, 7022-30.
  46. Walsh JG, Cullen SP, Sheridan C, et al (2008). Executioner caspase-3 and caspase-7 are functionally distinct proteases. Proc Natl Acad Sci, 105, 12815-9.
  47. Xiang J, Chao DT, Korsmeyer SJ (1996). BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc Natl Acad Sci, 93, 14559-63.
  48. Wang C, Youle RJ (2009). The role of mitochondria in apoptosis. Annu Rev Genet, 43, 95-118.
  49. Westphal D, Dewson G, Czabotar PE, Kluck RM (2011). Molecular biology of Bax and Bak activation and action. Biochim Biophys Acta, 1813, 521-31.
  50. Witcher M, Ross DT, Rousseau C, Deluca L, Miller WH Jr (2003). Synergy between all-trans retinoic acid and tumor necrosis factor pathways in acute leukemia cells. Blood, 102, 237-45.
  51. Yang XH, Sladek TL, Liu X, et al (2001). Reconstitution of caspase-3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Cancer Res, 61, 348-54.
  52. Youle RJ, Strasser A (2008). The $Bcl_2$ protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol, 9, 47-59.
  53. Yu LL, Wu JG, Dai N, Yu HG, Si JM (2011). Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-${\kappa}B$ transcription factor. Oncol Rep, 26, 1197-203.
  54. Zamzami N, Susin SA, Marchetti P, et al (1996). Mitochondrial control of nuclear apoptosis. J Exp Med, 18, 1533-44.
  55. Ziegler U, Groscurth P (2004). Morphological features of cell death. News Physiol Sci, 19, 124-8.

Cited by

  1. 3D QSAR and pharmacophore study of curcuminoids and curcumin analogs: Interaction with thioredoxin reductase vol.5, pp.4, 2013,
  2. 20(S)-Protopanaxadiol Induces Human Breast Cancer MCF-7 Apoptosis through a Caspase-Mediated Pathway vol.15, pp.18, 2014,
  3. Curcumin Induces Apoptosis in SGC-7901 Gastric Adenocarcinoma Cells via Regulation of Mitochondrial Signaling Pathways vol.15, pp.9, 2014,
  4. Hybrid Curcumin Compounds: A New Strategy for Cancer Treatment vol.19, pp.12, 2014,
  5. Study of interaction of human serum albumin with curcumin by NMR and docking vol.20, pp.8, 2014,
  6. Protective Effect of Curcumin on Acute Airway Inflammation of Allergic Asthma in Mice Through Notch1–GATA3 Signaling Pathway vol.37, pp.5, 2014,
  7. Hesperidin from Citrus seed induces human hepatocellular carcinoma HepG2 cell apoptosis via both mitochondrial and death receptor pathways vol.37, pp.1, 2016,
  8. The Anti-Cancer Effect of Polyphenols against Breast Cancer and Cancer Stem Cells: Molecular Mechanisms vol.8, pp.9, 2016,
  9. Curcumin reduces mitomycin C resistance in breast cancer stem cells by regulating Bcl-2 family-mediated apoptosis vol.17, pp.1, 2017,
  10. Curcumin reduces lung inflammation via Wnt/β-catenin signaling in mouse model of asthma vol.54, pp.4, 2017,
  11. The influence of diet on anti-cancer immune responsiveness vol.16, pp.1, 2018,
  12. Curcumin and Gastric Cancer: a Review on Mechanisms of Action pp.1941-6636, 2019,